The results indicated that treatment with sEVs derived from control cells significantly increased the migratory capacity of A549 cells, whereas sEVs derived from syntenin-1-knockdown cells diminished this effect (Fig. 3B–F), thereby suggesting that syntenin-1-mediated sEVs are crucial in inducing the migration of cancer cells. The gene discussed is SDCBP; the disease is cancer.